Financial statements Biocomp

Balance sheet of Biocomp

Company age:
Age:
3 y. 3 m. 20 d.
Share capital:
Share capital:
50 000 PLN
Profit and loss statement Balance Profitability

Balance sheet data of BIOCOMP

Year
2022
2023
Total assets 37 186,45 18 580 097,58
A. Fixed assets 0,00 9 535 040,01
B. Current assets 37 186,45 9 045 057,57
C. Share capital contributions (basic funds) - -
D. Own shares (stocks) - -
Total liabilities 37 186,45 18 580 097,58
A. Equity 35 467,85 159 573,87
B. Liabilities and provisions for liabilities 1 718,60 18 420 523,71
I. Long-term liabilities - 4 500 000,00
II. Short-term liabilities 1 718,60 13 920 523,71
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
  • Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
  • Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
  • Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
  • Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
  • Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
  • Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.